嵌合抗原受体
细胞疗法
细胞
T细胞
持久性(不连续性)
受体
细胞培养
癌症研究
免疫学
生物
细胞生物学
干细胞
免疫系统
遗传学
工程类
岩土工程
作者
Pei Wc,Jian Hu,Song Jh,WF Wang,He Yy,Wenjing Pang,Yanping Huang
出处
期刊:DOAJ: Directory of Open Access Journals - DOAJ
日期:2021-03-01
卷期号:25 (5): 2313-2317
被引量:1
标识
DOI:10.26355/eurrev_202103_25263
摘要
Adoptive CAR T cell therapy (chimeric antigen receptor T-Cell) has received increasing attention in recent years; however, its efficacy is undesirable and differs from person to person. Understanding how to overcome this obstacle is important to improve therapy. Infusion of poorly differentiated CAR-CD62L+ T cells, such as T memory stem cell populations, leads to enhanced T cell implantation, expansion, and persistence, which ultimately leads to more stable tumour regression. Here, we reviewed emerging findings demonstrating that CAR structure and cell culture conditions can influence CAR T cell differentiation and antitumour efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI